Skip to main content
GutCited

아연카르노신 관련 소화성 궤양

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

NSAID 유발 소장 손상을 70% 줄입니다(칼프로텍틴으로 측정). 위 점막 치유를 촉진합니다. 아연카르노신 복합체로 75~150mg/일 섭취합니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dzinc\u002Dcarnosine\u0026condition\u003Dgastric\u002Dulcer'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

NSAID 유발 소장 손상을 70% 줄입니다(칼프로텍틴으로 측정). 위 점막 치유를 촉진합니다. 아연카르노신 복합체로 75~150mg/일 섭취합니다.

Key Study Findings

Randomized Controlled Trial n=92
Zinc carnosine-based modified bismuth quadruple therapy vs standard triple therapy for Helicobacter pylori eradication: A …
Dose: Zinc carnosine 75 mg twice daily for 10 days vs: Standard triple therapy for 14 days Outcome: H. pylori eradication rate 효과: 93.5% vs 69.6% P=0.003

대상 집단: Dyspepsia patients with H. pylori infection

In Vitro
The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats.
Dose: 30 mg/kg vs: None Outcome: mineral status 효과: or 2 None

대상 집단: animal model

Key Statistics

6

연구

500

참여자

↑

Positive

B

등급

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
75 mg twice daily (as zinc carnosine complex)
nsaidprotection:
37.5-75 mg twice daily alongside NSAID therapy
gastricprotection:
75 mg twice daily for 8 weeks

상한량: 40 mg/day elemental zinc (equivalent to ~340 mg zinc carnosine); risk of copper depletion above this

연구에서 사용된 용량

용량 기간 효과 N
Zinc carnosine 75 mg twice daily for 10 days -- Positive 92
30 mg/kg -- Positive --

권장 복용 시간: On an empty stomach or between meals for gastric mucosal contact; twice daily

Safety & Side Effects

보고된 부작용

  • ⚠ Nausea (most common, usually transient)
  • ⚠ Metallic taste
  • ⚠ Copper depletion with long-term high-dose use (>40 mg elemental zinc/day)
  • ⚠ Headache

알려진 상호작용

  • ● Tetracycline and quinolone antibiotics (zinc reduces absorption; space 2 hours)
  • ● Penicillamine (zinc reduces absorption)
  • ● Copper supplements (zinc competes with copper for absorption)
  • ● Bisphosphonates (zinc may reduce absorption; space 2 hours)

일일 최대 섭취 허용량: 40 mg/day elemental zinc (equivalent to ~340 mg zinc carnosine); risk of copper depletion above this

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 아연카르노신 help with 소화성 궤양?
Based on 6 studies with 500 participants, there is moderate evidence from clinical studies that 아연카르노신 may support 소화성 궤양 management. Our evidence grade is B (Good Evidence).
How much 아연카르노신 should I take for 소화성 궤양?
Studies have used various dosages. A commonly studied range is 75 mg twice daily (as zinc carnosine complex). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 아연카르노신?
Reported side effects may include Nausea (most common, usually transient), Metallic taste, Copper depletion with long-term high-dose use (>40 mg elemental zinc/day), Headache. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 아연카르노신 and 소화성 궤양?
We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 500 total participants. The overall direction of effect is positive.

관련 다른 성분: 소화성 궤양

아연카르노신 다른 건강 상태에 대한 근거

References

  1. [1] Nour Ibrahim et al.. World J Clin Cases. 2022. Zinc carnosine-based modified bismuth quadruple therapy vs standard triple therapy for Helicobacter pylori eradication: A randomized controlled study. doi:10.12998/wjcc.v10.i1.227 PubMed
  2. [2] C H Cho et al.. Life Sci. 1991. The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats. doi:10.1016/0024-3205(91)90321-2 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.